By using data from the Cancer Genome Atlas, Yu et al. could identify different alternative splice variants that were significantly associated with overall survival in pancreatic cancer, e.g., DAZAP1, RBM4, ESRP1, QKI, and SF1 [64]. Here, RBM4 is linked to cancer.